Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study has tested if a daily, 4-week intake of a multispecies probiotic improved emotional processing in people with untreated moderate depression.

Bacteria Bifidobacterium, part of normal flora of human intestine, used as probiotics and in yoghurt production.

Dietary supplementation with probiotics - live cultures of "good" bacteria - has been shown to influence brain function, but the understanding of the underlaying mechanisms involved in this remain elusive.

Associate Professor Phil Burnet, Department of Psychiatry, University of Oxford, said:


'Our study shows that taking a probiotic supplement alters emotional processing and improves mood in people with moderate depression. These data provide further evidence for gut bacteria affecting human brain function.

'Understanding the influence of probiotics on emotions may suggest how they should be most effectively combined with other interventions in the treatment of mental health conditions. People with moderate depression are often reluctant to seek medical help as they may be worried about taking medication. Our findings suggest that probiotics could be used as an early intervention to help reduce the risk of people with mild to moderate depression developing a major depressive disorder, which is more debilitating and often difficult to treat. However, it is important to note that probiotics will never, and should not, replace current pharmacological and psychological therapies.'

The study included 71 participants in a randomised double-blind, placebo-controlled trial. Results showed that the participants who took the probiotic had increased accuracy at identifying faces expressing all emotions and vigilance to neutral faces, this is different to the reported action of commonly used antidepressants, which reduce attention to negative emotions.

Associate Professor Burnet continues:

'Testing a larger population of people with other probiotics and narrowing down exactly which bacteria are influencing the processes in the periphery that lead to changes in the brain would be a helpful next step. This would then have the potential to lead to the development of new treatments for depression when conventional approaches may not be appropriate.'

Read the full paper, Multispecies probiotic administration reduces emotional salience and improves mood in subjects with moderate depression: a randomised, double-blind, placebo-controlled study.

Similar stories

Oxford researchers part of major UK initiative to understand chronic pain

Oxford pain researchers are playing a major role in a new multi-million pound research programme launched by a consortium of funders, including UKRI, Versus Arthritis, Eli Lilly and the Medical Research Foundation.

Unique study of vascular disease reaches 20th anniversary

The only project of its kind anywhere that studies patients with all types of acute vascular events - including strokes, heart attacks, aneurysms - in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.

DPAG launches “Body, Brain, Behavior: Three Views and a Conversation” in Oxford

The Oxford Book Launch 'Body Brain Behavior - The Need For Conversations' brought together three world leading scientist authors, Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch, with Oxford's neuroscience community on Thursday 7 April 2022.

Little understood brain region linked to how we perceive pain

A new review paper, published in the journal Brain, has shown that a poorly understood region of the brain called the claustrum may play an important role in how we experience pain.